Iterative Decomposition of Water and Fat with Echo Asymmetry and Least-Squares Estimation (IDEAL) Magnetic Resonance Imaging as a Biomarker for Symptomatic Multiple Myeloma.
Takasu M et al. PLoS One. 2015 Feb 23;10(2):e0116842. doi: 10.1371/journal.pone.0116842.

Serum free light chain reduction correlates with response and progression-free survival following carfilzomib therapy in relapsed/refractory multiple myeloma.
Vij R et al. Leuk Lymphoma. 2015 Feb 20:1-12. [Epub ahead of print].

Biodistribution and radiation dosimetry for the novel chemokine receptor CXCR4 targeting probe 68Ga-Pentixafor.
Herrmann K et al. J Nucl Med. 2015 Feb 19. pii: jnumed.114.151647. [Epub ahead of print].

Marked Variability in Reported Minimal Residual Disease Lower Level of Detection of 4 Hematolymphoid Neoplasms: A Survey of Participants in the College of American Pathologists’ Flow Cytometry Proficiency Testing Program.
Keeney M et al. Arch Pathol Lab Med. 2015 Feb 19. [Epub ahead of print].

Content of endothelial progenitor cells in autologous stem cell grafts predict survival after transplant in multiple myeloma.
Blix ES et al. Biol Blood Marrow Transplant. 2015 Feb 14. pii: S1083-8791(14)01471-2. doi: 10.1016/j.bbmt.2014.12.027. [Epub ahead of print].

Comparison of the quality of different magnetic resonance image sequences of multiple myeloma.
Sun ZY et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2015 Feb 12;37(1):50-4. doi: 10.3881/j.issn.1000-503X.2015.01.009.

The Utility of SPECT/CT Fusion Imaging in the Diagnosis of a Vertebral Compression Fracture in Multiple Myeloma.
Kwok IH et al. Spine J. 2015 Feb 6. pii: S1529-9430(15)00106-0. doi: 10.1016/j.spinee.2015.02.008. [Epub ahead of print].

Clinical impact of immunophenotypic remission after allogeneic hematopoietic cell transplantation in multiple myeloma.
Giaccone L et al. Bone Marrow Transplant. 2015 Feb 9. doi: 10.1038/bmt.2014.319. [Epub ahead of print].

Minimal residual disease in myeloma by flow cytometry: independent prediction of survival benefit per log reduction.
Rawstron AC et al. Blood. 2015 Feb 2. pii: blood-2014-07-590166. [Epub ahead of print].

Successful mobilization of PBSCs predicts favorable outcomes in multiple myeloma patients treated with novel agents and autologous transplantation.
Brioli A et al. Bone Marrow Transplant. 2015 Feb 2. doi: 10.1038/bmt.2014.322. [Epub ahead of print].

Role of additional chromosomal changes in the prognostic value of t(4;14) and del(17p) in multiple myeloma: the IFM experience.
Hebraud B et al. Blood. 2015 Jan 30. pii: blood-2014-07-587964. [Epub ahead of print].

Circulating serum levels of IL-20 in multiple myeloma patients: its significance in angiogenesis and disease activity.
Alexandrakis MG et al. Med Oncol. 2015 Mar;32(3):488. doi: 10.1007/s12032-015-0488-z. Epub 2015 Jan 29